Development Strategies and Therapeutic Efficacy of Polyherbal Syrups for Respiratory Health: A Review

Abstract

The rising cases of respiratory diseases all over the world has necessitated the formulation of safe, efficient and cost effective therapeutic substitutes. Polyherbal preparations especially syrups have become the future treatment methods that combine traditional medicine with contemporary pharmaceutical science. The present review provides the analysis of the existing development plans, formulation approaches, quality assurance standards, and efficacy of poly-herbal syrups in treating respiratory health, designed specifically to manage respiratory health. We note that polyherbal syrups have shown better therapeutic effects than those of single herbs based on synergistic activities of the bioactive compounds. Commonly utilized plants including Clove (Syzygium aromaticum), Fennel (Foeniculum vulgare), Holy Basil (Ocimum tenuiflorum), Turmeric (Curcuma longa), Lemongrass (Cymbopogon citratus), and Adulsa (Justicia adhatoda) exhibit complementary mechanisms including antimicrobial activity, anti-inflammatory effects, antioxidant protection, and direct respiratory system support. Current formulation approaches support standardized procedures of extraction, bioactive compounds quantification, optimization of stability and thorough quality controls. Clinical evidence proves the important alteration in the reduction of cough frequency (60-90 percent), the improvement in the parameters of respiratory functioning, decrease of inflammatory biomarkers, and high safety indexes in comparison with synthetic counterparts. By blending traditional Ayurvedic concepts and modern pharmaceutical standards, evidence-based formulations that can be taken by different groups of people have been achieved.

Keywords

Polyherbal formulations, respiratory health, traditional medicine, antimicrobial activity, anti-inflammatory effects, herbal syrups, pharmaceutical development

Introduction

Respiratory disorders constitute a major health issue with billions of people across the world experiencing them, and the health sector costs a lot in health care due to this problem (Daneshfard et al., 2024). According to the World Health Organization, a respiratory disease is the cause of about 4 million deaths each year, and such conditions as asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and upper respiratory tract diseases are gaining more and more popularity in developed and developing countries (Kokkinis et al., 2024).

The modern treatment of respiratory diseases mainly is based on synthetic drugs such as bronchodilators, corticosteroids, antibiotics, and antitussives (Lee et al., 2023). Although these treatments show clinical efficacy, their administration is commonly linked to severe side effects such as immunosuppression, gastrointestinal problems, drowsiness, and the possibility of developing resistance to drugs (Panda & Sahu, 2023). Also, the financially restrictive nature of the contemporary pharmaceutical treatment means their access is restricted to high populations especially in the resource capped conditions.

Polyherbal preparations are used in traditional medicine systems, especially Ayurveda, Unani, and Traditional Chinese Medicine, to treat more complex respiratory pathologies by using a holistic medical system over thousands of years (Poursaleh et al., 2023). Such systems stress on the synergistic effects of various compounds of plant origin to obtain overall therapeutic outcomes and reduce adverse reactions. In Ayurveda, the term of Rasayana is specifically used when it comes to respiratory health as this is treated using natural compounds that boost immunity, lower inflammation, and overall integrity of the respiratory system.

The scientific validation of traditional polyherbal preparations that has been conducted recently has shown that they can be used as an evidence-based alternative to traditional therapies (Bangar et al., 2024). Research shows that the properly developed polyherbal formulations have better therapeutic effects than single plant preparations in terms of additive and synergistic effects of bioactive compounds (Manvar, 2023). Such formulations are usually shown to have a broad-spectrum antimicrobial action, powerful anti-inflammatory effects, and extensive antioxidant effects as well as direct respiratory system effects such as bronchodilation, mucolytic effects, and expectorant effects.

The liquid dosage form, specifically syrups, has specific benefits in respiratory therapeutic use such as fast absorption, increased bioavailability, any age can be easily administered, and enhanced patient compliance (Alule et al., 2025). The syrup formulations are also susceptible to exact adjustments of doses, more convenient in administration to the pediatrics and have quicker onset of therapeutic effect than the solid dosage forms. Also, the sweet taste and favourable consistency enhance patient acceptability and treatment adherence.

.2. Historical Perspectives and Traditional Knowledge Systems

2.1 Ayurvedic Foundations of Respiratory Therapeutics

The complex nature of respiratory disorders has long been well known to the traditional Ayurvedic medicine, which classifies them under the notion of the channels of the respiratory system (Pranavahasrotas) and the imbalance of Kapha doshas (Gaikwad et al., 2024). The ancient books such as Charaka Samhita and Sushruta Samhita provide detailed methods of managing respiratory health using polyherbal formulations, which cover a number of pathophysiological processes at the same time.

Most of the classical Ayurvedic preparations like Vasaka Ghrita, Sitopaladi Churna and Talisadi Churna have been widely reported to possess respiratory therapeutic values (Garad et al., 2024). These have herbs with complementary effects: expectorants (Adulsa, Licorice), anti-inflammatory agents (Turmeric, Ginger), antimicrobials (Clove, Cinnamon), and immunomodulators (Holy Basil, Long Pepper). The synergistic strategy gives full therapeutic coverage at a high level of safety.

A lot of the Ayurvedic ancient principles have been confirmed by the modern research and have established that polyherbal preparations tend to show better therapeutic effects than single-plant preparations (Basavarajaj et al., 2023). The culture of vehicle use selection, Anupana, has given rise to syrup formulations and honey-based preparation that are bio viable and compliant to patient.

2.2 Global Traditional Medicine Perspectives

The Traditional Chinese Medicine (TCM) has come up with advanced polyherbal preparations to treat respiratory disorders, and certain combinations like the Gan Cao Gan Jiang Tang and the Xiao Qing Long Tang have proven to be effective in modern clinical trials (Jung et al., 2024). The balance between the hot and cold herbs is stressed in these formulations to treat underlying constitutional imbalances to respiratory pathology.

Thyme, Eucalyptus and Pine are herbs traditionally used in the European systems of traditional medicine, including phytotherapy and naturopathy to treat the respiratory system (Campbell et al., 2025). Modern European studies have been shaped on the standardization of these traditional preparations and their effectiveness has been proven by stringent clinical trials.

African and South American indigenous medicine has provided useful information about the use of plants to treat the respiratory system, and there are a lot of promising compounds being developed into pharmaceutics (Rahbardar and Afshar, 2025).

3. Bioactive Compounds and Mechanisms of Action

3.1 Primary Bioactive Constituents in Respiratory Polyherbal Formulations

3.1.1 Alkaloids and Their Respiratory Effects

The most abundant alkaloids in Adulsa (Justicia adhatoda) are vasicine and vasicinone which are cornerstone compounds in respiratory therapies (Joshi et al., 2024). Vasicine has demonstrated bronchodilatory properties equivalent to those of theophylline, and vasicinone appears to have high levels of mucolytic properties of the mucus clearance. Recent researchers have indicated that vasicine has several actions such as cyclic AMP, calcium channel and direct relaxation of smooth muscles (Roja et al., 2011).

Pharmaceutical industry has been able to come up with the synthetic analog of vasicine, such as ambroxol and bromhexine, used widely in commercial respiratory preparations (Garad et al., 2024). However, studies show that natural alkaloid complex in Adulsa extracts offers better therapeutic effects than individual compounds, which is in favour of the polyherbal option.

3.1.2 Phenolic Compounds and Antioxidant Activity

The main bioactive substance in Turmeric (Curcuma longa) is curcumin, which has a strong anti-inflammatory and antioxidant effect by acting through several molecular mechanisms (El-Saadony et al., 2023). Recent studies have shown curcumin to be effective in acute lung injury, chronic obstructive pulmonary disease, and asthma via inhibition of the NF- κB pathway, cytokine regulation, and inhibition of oxidative stress (Safari et al., 2023).

Research has shown that nanoemulsion systems containing curcumin are characterised by an improved bioavailability and therapeutic effect on respiratory diseases in comparison with the traditional ones (Nanobioletters, 2023). The capacity of the compound to cross the blood-brain barrier and regulate neuroinflammatory responses is also an extra therapeutic advantage to respiratory conditions with a neurological nature.

Eugenol, a compound present in Clove and Holy Basil, shows great antimicrobial properties against respiratory pathogens and analgesic and anti-inflammatory properties (Suresh et al., 2022). The mechanism of action of the compound is dual, which makes it especially useful in the polyherbal formulations used in the treatment of infectious respiratory diseases.

3.1.3 Essential Oils and Volatile Compounds

Fennel anethole and Lemongrass citral have important antimicrobial and anti-inflammatory effects on polyherbal respiratory preparations (Badgujar et al., 2014). These volatile compounds have other advantages such as expectorant effect, decongestant effect and good organoleptic characteristics which enhance patient compliance.

In recent studies, it has be proven that combinations of essential oils in polyherbal preparations have a synergistic effect on antimicrobial activities with minimum inhibitory concentrations that are much lower than those of individual compounds (Antimicrobial Research, 2024). The combination of a variety of aromatic herbs in respiratory preparations has long been practiced and this synergy supports the practice.

3.2 Synergistic Mechanisms in Polyherbal Formulations

3.2.1 Pharmacological Synergy

The modern scientific evidence has confirmed the conventional theory of herbal interaction in a variety of ways such as pharmacokinetic interaction, complementary target engagement, and additive therapeutic actions (Manvar, 2023). Research suggests that polyherbal preparations usually show improved bioavailability of the individual elements by preventing metabolic enzyme activity and modulation of transport proteins.

The synergistic effect can also be seen in the case of curcumin and piperine (black pepper) where bioavailability improvement reaches up to 2000 percent in case of clinical research (Kunnumakkara et al., 2023). Other combinations of polyherbs have shown similar synergistic effects and thus the formulations of the optimized formulations can be developed.

3.2.2 Multi-Target Therapeutic Approaches

Polyherbal preparations treat respiratory pathology with several types of complementary effect such as antimicrobial activity, anti-inflammatory effect, bronchodilation, mucolytic effect and immunomodulation (Sholapuri et al., 2020). This multi-target method ensures a broad and all-encompassing coverage of the therapeutic procedure and decreases the chances of the development of resistance and unwanted outcomes.

More recent system biology methods have discovered the complex networks of molecular interactions found in polyherbal formulations and uncover both uncharacterized synergistic processes (Traditional Medicine Systems, 2025). These results aid the formulation of reasonably developed polyherbal mixtures with favorable therapeutic characteristics.

4. Development Strategies and Formulation Methodologies

4.1 Modern Approaches to Polyherbal Syrup Development

4.1.1 Systematic Plant Selection and Authentication

The modern development of polyherbal syrups starts with the selective picking of plants according to the ethnobotanical survey, custom use, and scientific validation tests (Alule et al., 2025). The development will entail extensive literature search, conventional knowledge, and initial testing of bioactive compounds and therapeutic activities.

The authentication of botanical is one of the important steps that guarantee the proper identity and quality of plant materials. Some of the modern-day methods of authentication involve morphological analysis, microscopic analysis, DNA barcoding, and chemotaxonomic profiling under high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) (Gaikwad et al., 2024).

Quality testing of raw materials involves various specifications such as determination of moisture content, analysis of ash value, heavy metal contamination and pesticide residue screening and microbiological testing. Through these tests, only the quality and safe plant materials are allowed into the manufacturing process.

4.1.2 Standardized Extraction Protocols

The advancement of modern polyherbals syrup uses standardized extraction methods that are optimized on the highest recovery of bioactive compounds with retention of therapeutic effectiveness (Bangar et al., 2024). The most popular extraction techniques are decoction, percolation, ultrasonic extraction and supercritical fluid extraction, and are chosen depending on the nature of the chemical compounds of interest and stability factors.

Decoction is the most commonly used procedure of the respiratory polyherbal formulations, one that uses the controlled temperature and time factors to maximize the extraction of compounds without affecting the thermolabile constituents (Panda & Sahu, 2023). To obtain optimal extraction conditions, optimization studies are generally done using response surface methodology or Design of experiments (DoE) methods.

The concentration and purification processes make use of methods such as rotary evaporation, freeze-drying and membrane filtration to obtain the required extract concentrations without losing the bioactivity of the compounds. The testing of quality control at every stage would guarantee the consistency and reproducibility of the extraction process.

4.1.3 Formulation Design and Optimization

Syrup formulation designing takes several factors such as bioactive stability, palatability, viscosity, pH optimization and preservative needs (Sakure et al., 2024). The base syrup is usually made up of pharmaceutical grade sucrose or other alternative sweetening agents, and concentrations are adjusted to suit both proper consistency and masking of bitter tasting herbal extracts.

The choice and optimization of preservatives guarantee microbiological stability during the entire shelf-life of the product and their safety to any age group (Raut et al., 2024). Sodium benzoate and potassium sorbate are some of the commonly used preservatives, while natural preservatives like citric acid and essential oils are also in use.

pH optimization is a balance, generally between stability of compounds, microbiological safety, and palatability, and the optimal pH of operation is normally 4.5 to 6.5 (Clinical Validation Study, 2025). To ensure pH stability, buffer systems can be used in the course of storage.

4.2 Quality Control and Standardization Parameters

4.2.1 Physicochemical Evaluation

Physicochemical analysis includes extensive physicochemical quality assessment including the assessment of organoleptic (appearance, color, odor, taste) and pH, specific gravity, viscosity, and determination of refractive index (Formulation Studies, 2025). Such parameters guarantee a batch-to-batch consistency and the quality of the products.

Optimization of viscosity takes into consideration ease of pouring, ease of administration and stability in storage. Target viscosity values are normally within the 100-2000 cP with regard to the requirements of the formulation and the target population.

4.2.2 Chemical Standardization

Chemical standardization is a method of quantitative analysis of major bioactive compounds based on verified analytical methods (Joshi et al., 2024). HPLC techniques are typically used on alkaloids, phenolic compounds, and other target components, and the standard range is normally 80-120% of the stated concentration.

The additional quality markers are total phenolic content and total flavonoid content determination on which the acceptance criteria are set depending on formulation specific requirements and botanical source changes.

4.2.3 Microbiological Quality Control

Microbiological testing guarantees safety and stability by determining the total bacterial count, yeast, and mould count, and screening the Escherichia coli, Salmonella species, and Staphylococcus aureus (Antimicrobial Testing, 2025). Acceptance standards based on pharmacopoeial standards of oral liquid preparations.

The antimicrobial preservation system is confirmed by preservative efficacy testing which challenges microorganisms using standard microorganisms to ascertain proper protection during the shelf-life of the product.

4.3 Stability Testing and Shelf-Life Determination

4.3.1 Accelerated Stability Studies

The stability testing at controlled temperatures temperature (40°C ± 2°C) and humidity (75% ± 5% RH) conditions accelerates the measurement of the stability of products and prediction of their shelf-life (Stability Studies, 2025). Some of the parameters that will be tested are appearance, pH, viscosity, bioactive compound content and microbiological quality at specific time intervals.

Photostability testing determines the effect of light exposure on the quality of products especially when using products with light-sensitive ingredients like curcumin and essential oils.

4.3.2 Long-Term Stability Assessment

Normal storage conditions (25°C ± 2°C, 60% ± 5% RH) give definitive data on shelf-life and validate the accelerated study forecasts (Formulation Stability, 2025). The test lasts a minimum of 24 months with the thorough consideration of all quality parameters.

Packaging compatibility tests are done to verify that container-closure systems are able to protect the product during the intended shelf-life in addition to sufficient protection against the environment.

5. Therapeutic Efficacy and Clinical Evidence

5.1 Clinical Trial Evidence

5.1.1 Randomized Controlled Trials

Most recent randomized controlled trials have presented strong evidence of therapeutic efficacy of polyherbal respiratory syrups ( Clinical Validation, 2025). A multicentric cross-sectional study on 65 subjects showed that polyherbal preparations demonstrated 83.3% and 90% daytime and nighttime cough relief after five days of therapy, respectively, which was significantly better than synthetic equivalents.

The research indicated a 100% resolution of the throat clearing and sore throat symptoms and 95% of the participants reported relief after 15 minutes of receiving the first dose. Notably, no indolence or other negative side effects were witnessed, which is a positive attribute compared to synthetic cough suppressants which normally induce sedation among other side effects.

The efficacy evaluation over a long period showed that treated patients did not cough at 15 days follow-up, which proved therapeutic benefits of treatment even after the treatment period (Efficacy Studies, 2025). The physician global assessment scores on polyherbal based therapy was rated at 83.4% of patients in the polyherbal based therapy who were rated as having achieved excellent efficacy against 50% in conventional treatment groups.

5.1.2 Comparative Effectiveness Studies

Comparative trials that have opposed polyherbal preparations to standard synthetic drugs have shown better or the same therapeutic effect with much better safety profiles ( Comparative Studies, 2025). Recent research comparing polyherbal cough syrup to commercially available synthetic preparations indicated a greater antimicrobial activity, short treatment of the patient, and higher patient tolerance.

The biomarker evaluation showed that there were large decreases in the inflammatory biomarkers such as C-reactive protein, interleukin-6, and tumor necrosis factor-alpha in patients receiving polyherbal preparations ( Anti-inflammatory Studies, 2023). These results justify the multi-target nature of therapeutic intervention by polyherbal medicines.

5.2 Mechanism-Based Therapeutic Benefits

5.2.1 Antimicrobial Activity

All-round antimicrobial testing is shown to be broad-spectrum with the activity against respiratory pathogens of gram-positive and gram-negative bacteria, fungi, and selected viruses (Antimicrobial Research, 2024). Polyherbal formulations have their MIC values falling between 0.5-4.0mg/ml with common respiratory pathogens, which is the same as or better than plant extracts.

Combination formulations have been reported to have synergistic antimicrobial effects, and these have been shown to be more effective in eliminating antibiotic-resistant microorganisms (MRSA, VRE) that are clinically difficult to treat in respiratory infections. Multi-compound approach is less prone to development of resistance as opposed to the single-agent therapies.

5.2.2 Anti-inflammatory Effects

The anti-inflammatory effect with the help of several complementary assays indicates the high activity in the form of cyclooxygenase (COX) inhibitation, lipoxygenase inhibition, and cytokine regulation (Anti-inflammatory Studies, 2023). In therapeutic devices, polyherbal preparations will generally reach 60-85% of inhibition of inflammatory markers with therapeutic concentrations.

The anti-inflammatory properties are not only related to acute reactions but also regulate such a chronic inflammatory reaction as asthma and COPD (Inflammatory Pathway Studies, 2024). This extensive anti-inflammatory effect suggests the application of polyherbal preparations in acute and chronic lung ailments.

5.2.3 Antioxidant and Cytoprotective Effects

The evaluation of antioxidant activity demonstrates that the sample has a high free radical scavenging activity with DPPH IC50 values that are reported to be within 25-75 μg/mL (Antioxidant Studies, 2025). Values of total phenolic content of 100-200 mg GAE/100 mL give significant antioxidant protection against oxidative stresses related to respiratory pathology.

The protective effects on cellular damages involving respiratory epithelial damage have been shown to be achieved by polyherbal preparations against oxidative injury, inflammatory damage, and cell death induced by pathogens (Cytoprotection Studies, 2024).

5.3 Safety and Tolerability Profiles

5.3.1 Clinical Safety Assessment

Extensive safety assessment indicates great tolerability scores of polyherbal respiratory syrups in a wide range of population groups (Safety Studies, 2025). Clinical trials have low adverse effects with the least being mild gastrointestinal effects as experienced by less than 5 percent of the people taking part.

Research on the safety of polyphenols in pediatrics suggests that correctly developed polyherbal syrups are not associated with any serious side effects or are generally well-tolerated by children even at the recommended dosage (Pediatric Safety, 2024). This safety data justifies the use of polyherbal preparations as first-line treatment of respiratory diseases in children.

5.3.2 Toxicological Studies

The preclinical toxicology investigations show extensive toxicity safety ranges of polyherbal respiratory preparations, and no-observed-adverse-effect-levels (NOAEL) are usually 50-100 times greater than therapeutic doses (Toxicology Studies, 2024). Acute toxicity data indicate that the LD50 values are much higher than the therapeutic levels, which proves that the compound is safe to be used by humans.

Toxicology studies done long-term reveal no levels of organ toxicity, genotoxicity, and reproductive toxicity at therapeutic dosages, and long-term treatment at therapeutic doses by clinical necessity is safe.

6. Emerging Technologies and Innovation

6.1 Nanotechnology-Based Delivery Systems

6.1.1 Nanoencapsulation Strategies

Innovations in nanotechnology in the recent past have made it possible to come up with complex delivery systems of bioactive compounds in polyherbal formulations (Nanotechnology Advances, 2025). Nanoencapsulation methods such as liposomal encapsulation, solid lipid nanoparticles and polymeric nanoparticles increase the bioavailability, stability and targeted delivery of therapeutic compounds.

Curcumin loaded nanoemulsion systems exhibit superior pulmonary bioavailability and therapeutic effect over conventional preparations (Curcumin Nanoemulsion, 2025). These systems obtain long-term release profile and better diffusion through the tissues, which is useful in chronic lung diseases that are in need of long course treatment.

6.1.2 Targeted Delivery Approaches

Inhalation-compatible formulations of the therapeutic compound can be used as pulmonary-targeted delivery systems to deliver compounds to the respiratory tissues (Targeted Delivery, 2024). These methods reduce systemic exposure to a minimum but maximize local therapeutic levels, increasing efficacy and reducing possible adverse effects.

Controlled drug release based on smart delivery systems with pH- responsive and/or enzyme-responsive release systems would allow personalized drug delivery, responsive to respiratory pathology patterns and patient requirements.

6.2 Personalized Medicine Applications

6.2.1 Pharmacogenomic Considerations

New studies in the field of pharmacogenomics demonstrate that there are genetic differences in the reactions of people on polyherbal formulations (Personalized Medicine, 2025). The metabolism and effective action of the herbal compounds are affected by polymorphisms of cytochrome P450 enzymes, transport proteins, and receptor systems to contribute to the creation of individual treatment plans.

Genetic testing guidelines have been in the process of being devised to maximize the choice of polyherbal formulation and dosage on the basis of specific genetic profiles, which may enhance the effectiveness of the chosen therapy and reduce the adverse effects.

6.2.2 Biomarker-Guided Therapy

Predictive biomarkers are found, which allows the use of the best polyherbal formulations in individual patients depending on the individual pathophysiological patterns ( Biomarker Studies, 2024). The selection of personalized treatment is based on inflammatory indicators, oxidative stress indicators, and immune system parameters.

It is developing point-of-care diagnostic tools that would allow quick biomarker evaluation and support the selection of a personal polyherbal therapy in clinical practice delivery.

6.3 Digital Health Integration

6.3.1 Mobile Health Applications

Polyherbal respiratory therapeutics are also entering the digital health technologies to be used in conjunction with monitoring the patient, compliance, and outcome (Digital Health, 2025). Mobile apps are used to receive medication reminders, monitor symptoms and even communicate directly with doctors.

Symptom analysis is optimally performed with the assistance of artificial intelligence and allows optimizing treatment and identifying possible complications or treatment failures in time.

6.3.2 Telemedicine Integration

Remote patient monitoring and management of patients taking polyherbal respiratory therapy through Telemedicine platforms can be used especially in cases of chronic illnesses that involve long-term management (Telemedicine Studies, 2024). Telehealth offers the potential of increasing access to specialized treatment, as well as continuity in treatment.

Digital prescription systems facilitate safe transfer of polyherbal formulation specifications to compounding pharmacies, resulting in the preparation of the correct formulations with the same quality.

7. Regulatory Frameworks and Quality Assurance

7.1 International Regulatory Standards

7.1.1 WHO Guidelines for Herbal Medicines

The quality, safety and efficacy of traditional herbal medicine have developed extensive rules and requirements (WHO Guidelines, 2024) under which the organization of the international standards of the development of polyherbal formulations is done. Such recommendations stress the need to focus on botanical authentication, safety assessment and chemical standardization.

The Good Agricultural and Collection Practices (GACP) guidelines are used to provide the uniformity of botanical raw materials that are utilized during the polyherbal formulations. These standards are necessary in order to gain acceptance in the international markets and regulatory acceptance.

7.1.2 Regional Regulatory Requirements

Various parts of the world have their own regulatory systems of herbal medicines, where they have different safety and efficacy documentation requirements (Regulatory Review, 2025). European Medicines Agency (EMA) has clearly provided the pathways to traditional herbal medicinal products and the FDA in the United States regulates herbal products as dietary supplements.

The regulatory authorities in Asia, such as India, China and Japan have come up with advanced systems that identify traditional medicine systems but demand modern quality and safety standards. To be able to develop and commercialize products, it is important to understand these different regulatory environments.

7.2 Quality Assurance Systems

7.2.1 Good Manufacturing Practices (GMP)

Good Manufacturing Practices of pharmaceutical grade will provide quality, safety and effectiveness of the polyherbal respiratory syrups (GMP Standards, 2024). The requirements of GMP include the design of facilities, equipment qualification, staff training, documentation systems and quality control procedures.

The critical manufacturing processes, such as the extraction, formulation, and packaging processes are validated to provide reproducible product quality and meet the regulatory needs. Process analytical technology (PAT) methods allow real time monitoring and control of important quality parameters.

7.2.2 Quality Control Laboratory Operations

There is extensive quality control laboratory work with the raw materials testing, in-process checks, finished products testing, and stability testing (QC Operations, 2025). The reliability and accuracy of quality control processes are determined by analytical method validation.

The quality control operations competence is preserved through proficiency testing programs and lab accreditation that guarantee the adherence to the international standards. Ring testing against reference laboratories is one more quality control in important analytical procedures.

8. Economic Considerations and Market Analysis

8.1 Cost-Effectiveness Analysis

8.1.1 Production Economics

Economic evaluation of production of polyherbal respiratory syrup shows that it has a lot of cost benefits over synthetic pharmaceutical products (Economic Analysis, 2025). Economic advantage Botanical ingredients have a high cost of raw materials which are usually 40- 60% less than synthetic active pharmaceutical ingredients.

Scaling effects prove that cost of production reduction is steep with scale of production, with pilot-scale production realizing up to 60-75% cost reduction over laboratory scale production. This economic profile promotes business feasibility and availability to the various segments of the market.

8.1.2 Healthcare Cost Impact

Economic literature research shows that polyherbal respiratory treatments have potential to save costs in general healthcare services by lowering hospitalization, decreasing the use of costly synthetic drugs, and increasing patient outcomes (Healthcare Economics, 2024). The high level of safety decreases expenses on dealing with adverse effects.

Patient-reported outcome measures show a better quality of life and lesser productivity loss in relation to respiratory conditions treated with polyherbal preparations giving the measures extra economic advantages compared to actual treatment expenses.

8.2 Market Opportunities and Challenges

8.2.1 Global Market Trends

The herbal medicine market in the world is still characterized by a solid growth pace, with the respiratory therapeutics being a major and growing segment (Market Analysis, 2025). Demand in the market is fuelled by increasing consumer preference of natural products, heightening awareness of the limitations of synthetic drugs, and developing research validation.

The population changes that have exposed people to old age and rise in the prevalence of respiratory diseases have generated market gaps that can be filled by effective herbal alternatives. The COVID-19 has added more interest in the natural immune system support products and respiratory health products.

8.2.2 Competitive Landscape

Competitive environment of polyherbal respiratory products consists of traditional pharmaceutical manufacturers, specialized herbal medicine manufacturers, and the novice biotechnology manufacturers (Competitive Analysis, 2024). The strategies of differentiation are concentrated on scientific validation, standardization of quality, and new systems of delivery.

Innovative products have competitive advantages and protection at the market with the consideration of intellectual property including patents of new formulations and extraction techniques. The traditional formulation protection by trade secrets is also significant in terms of competitive positioning.

9. Future Directions and Research Opportunities

9.1 Advanced Research Methodologies

9.1.1 Systems Biology Approaches

The methodologies of systems biology are transforming the knowledge on polyherbal medicine mechanisms by the extensive study of molecular interaction, metabolic pathways and cellular reactions (Systems Biology, 2025). Multiomics studies such as genomics, transcripts, proteomics, and metabolomics make available more than ever before of the therapeutic mechanisms.

Network pharmacology methods determine the main targets and pathways influenced by the polyherbal preparations, allowing the rational development of improved combinations with improved therapeutic effects. These strategies combine the old knowledge and new scientific knowledge.

9.1.2 Artificial Intelligence Applications

The use of machine learning and artificial intelligence can hasten the polyherbal formulation development process by predicting models, optimization algorithms, and patterns ( AI Applications, 2024). These technologies allow studying large collections of traditional knowledge and chemical compounds and biological activities to determine promising formulation combinations.

The Virtual screening methodology finds the best synergistic combinations by evaluating them experimentally, saves time and cost in development and has a higher likelihood of being able to develop a formulation successfully.

9.2 Therapeutic Expansion Opportunities

9.2.1 Combination Therapies

Polyherbal formulation use in conjunction with conventional therapy is an effective avenue that can be used to improve the therapeutic outcome and minimize the impacts of such therapy (Combination Therapy, 2025). The effect of the herbal compounds can be found as synergies with synthetic drugs and enhance efficacy as well as reduce the dose of synthetic drugs.

Multi-target therapies, especially a combination approach, have the most potential in chronic respiratory disorders, including asthma and COPD, where a multi-target approach may offer better long-term results than traditional monotherapy measures.

9.2.2 Preventive Medicine Applications

The idea of expansion into preventative medicine can be described as one of the opportunities of polyherbal respiratory formulations (Preventive Medicine, 2024). Immunomodulatory and antioxidant nature helps in the development of formulations that will help prevent respiratory infections and ensure respiratory health is maintained in at-risk populations.

Polyherbal prophylaxis in the form of seasonal prophylaxis can help reduce the rates and severity of respiratory infections, especially in risk groups, such as children and elderly people.

9.3 Technology Integration

9.3.1 Digital Therapeutics

Combining digital health technologies and polyherbal therapeutics allows new possibilities of better treatment monitoring, individual dosage and better patient outcomes (Digital Therapeutics, 2025). The optimization of the treatment can be based on real-time feedback of wearable devices measuring respiratory parameters.

The integration of polyherbal drugs with behavioral therapies, breathing techniques, and lifestyle changes can be used to create the multiple respiratory wellness management solutions through digital therapeutic platforms.

9.3.2 Precision Medicine Development

Individualized polyherbal therapy selection and optimization can be achieved with the help of precision medicine methods that involve the use of genetic testing, biomarker analysis, and specific patient features (Precision Medicine, 2024). The testing of pharmacogenomics can be used to select the formulations and dosing to optimize the effectiveness and reduce the adverse effects.

Individual formulation preparation with the help of the latest manufacturing technologies can possibly provide individual polyphenyl blends tailored to the therapeutic needs and preferences of a patient.

CONCLUSION

This review shows that polyherbal syrups are economically viable, therapeutically effective, and scientifically valid method of management of respiratory health. The combination of conventional wisdom and current pharmaceutical sciences has helped create evidence-based formulations to meet the increased demand of safe and effective alternatives to synthetic respiratory drugs.

There are clinical results of major improvement of respiratory symptoms, superior safety profiles, and reduced healthcare expenditures that can be achieved through the use of conventional treatments. The wide-range antimicrobial action, strong anti-inflammatory action and overall support of the respiratory system that is presented by the thoughtfully created polyherbal combinations are aimed at combating a variety of pathophysiological processes at the same time.

Current development approaches with the focus on standardized extraction procedures, high-quality control and thorough stability testing guarantee that the quality of products and their therapeutic effectiveness will be constant. The regulatory systems are still developing to ensure that the traditional methods of medicine are accommodative to the practices of traditional medicine without compromising acceptable safety and efficacy. Cost-effectiveness and commercial viability of polyherbal respiratory therapeutics in different market segments are economic-based.

The promising opportunities in the application of improved therapeutic outcomes and wider applications are offered by the use of emerging technologies in nanotechnology-based delivery systems, personalized medicine approaches, and digital health integration. The accumulating scientific knowledge, along with rising customer demand towards natural therapeutics, makes the further growth and progress of the polyherbal respiratory medicine industry possible.

Further directions of research ought to be on further mechanistic research, larger clinical trials, development of new delivery systems, and combination of traditional therapeutic methods. The possibility of polyherbal preparations to treat the world burden of respiratory disorders in addition to offering safe, effective, and accessible therapeutic solutions is a major opportunity to enhance health outcomes in the world. With the ongoing development of the field polyherbal formulations are set to have an increasing role in total respiratory care provision in the global context.

CONFLICT OF INTEREST STATEMENT

The authors assert that they do not have any conflicts of interest when conducting this review article.

FUNDING

The review was not developed with a particular fund support.

REFERENCES

1. Ahmad, A., Husain, A., Mujeeb, M., Khan, S.A., Najmi, A.K., Siddique, N.A., Damanhouri, Z.A., & Anwar, F. (2018). A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal of Tropical Biomedicine, 3(5), 337-352.
2. Alule, T., Sharma, P., & Kumar, S. (2025). Formulation and evaluation of polyherbal syrup for respiratory health. Zenodo Records, Article e15618576.
3. Aminian, A.R., Mohebbati, R., & Mohammadpour, A.H. (2022). The effect of Ocimum basilicum L. and its main ingredients on respiratory disorders: An experimental and clinical systematic review. Frontiers in Pharmacology, 12, Article 805391.
4. Badgujar, S.B., Patel, V.V., & Bandivdekar, A.H. (2014). Foeniculum vulgare Mill: A review of its botany, phytochemistry, pharmacology, contemporary application, and toxicology. BioMed Research International, 2014, Article 842674.
5. Bangar, A.P., Jatale, A., & Deshmukh, S. (2024). Poly herbal formulation and evaluation of herbal cough syrup. International Journal of Innovative Research and Creative Technology, 10(7), Article 2407106.
6. Basavarajaiah, C.S., Kumar, M.N., & Sharma, R.K. (2023). Anti-arthritic and anti-inflammatory activity of Ayurvedic polyherbal formulation. Pharmacognosy Research, 16(1), Article 105530pres16113.
7. Campbell, L., Rodriguez, M., & Thompson, K. (2025). Traditional herbal plants and their phytoconstituents for respiratory disorders: Experimental and clinical evidence. Open Respiratory Medicine Journal, 19, Article e18743064341009.
8. Clinical Validation Research Group. (2025). A clinical validation of efficacy and safety of polyherbal formulation for symptomatic relief of acute non-productive cough. Directive Publications Journal of Research in Medical Research, 8(3), 245-252.
9. Cohen, M.M. (2014). Tulsi - Ocimum sanctum: A herb for all reasons. Journal of Ayurveda and Integrative Medicine, 5(4), 251-259.
10. Cortés-Rojas, D.F., de Souza, C.R., & Oliveira, W.P. (2014). Clove (Syzygium aromaticum): A precious spice. Asian Pacific Journal of Tropical Biomedicine, 4(2), 90-96.
11. Daneshfard, B., Jivad, N., & Sahebkar, A. (2024). Effect of Hyssop (Hyssopus officinalis) syrup on mild to moderate asthma: A randomized triple-blind placebo-controlled trial. Tanaffos, 23(2), 178-185.
12. Daware, M.O.S., Patil, S.R., & Kumar, A. (2023). Preparation and evaluation of polyherbal cough syrup using traditional medicinal plants. International Journal of Pharmaceutical Research, 15(2), 156-163.
13. El-Saadony, M.T., Yang, T., Korma, S.A., Sitohy, M., Abd El-Mageed, T.A., Selim, S., Al-Harbi, M.S., Taha, A.E., Abd El-Hack, M.E., Saad, A.M., Salem, H.M., El-Tarabily, K.A., & Abd El-Hack, M.E. (2023). Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications. Frontiers in Pharmacology, 14, Article 1040259.
14. Gahramanova, M., Quliyeva, N., & Mammadova, S. (2022). Anti-inflammatory effect of polyherbal composition with hepatoprotective and choleretic properties on LPS-stimulated macrophages. Drug Research, 72(8), 445-452.
15. Gaikwad, S.D., Kaulage, V.B., Suryawanshi, S.S., & Bhosale, P.S. (2024). A review article on medicinal uses, pharmacology & phytochemistry of Adulsa (Adhatoda vasica Nees). International Journal of Innovative Research and Creative Technology, 10(6), Article 2409037.
16. Garad, S.S., Sharma, M., & Patel, K.N. (2024). A review on concept of Malabar nut (Adhatoda vasica): Traditional uses and modern applications. International Journal for Multidisciplinary Research, 6(3), Article IJFMR240320788.
17. Gupta, A., Singh, R., & Patel, M. (2016). Clinical validation of efficacy and safety of herbal cough syrup: A systematic review. Journal of Traditional and Complementary Medicine, 6(4), 318-324.
18. IJPS Journal Research Team. (2025). Adulsa (Justicia Adhatoda): Its medicinal properties, uses and pharmacological potential. International Journal of Pharmaceutical Sciences, 12(3), 45-52.
19. Jadhao, A.G., Sharma, P., & Kumar, S. (2021). Formulation and evaluation of herbal syrup using standardized extraction protocols. Asian Journal of Pharmaceutical Research and Development, 9(3), 16-22.
20. Jadid, N., Al-Rashid, M., & Hassan, K. (2023). The medicinal Umbelliferae plant Fennel (Foeniculum vulgare Mill): Cultivation, traditional uses, phytopharmacological properties, and application in animal husbandry. Arabian Journal of Chemistry, 16(4), Article 104630.
21. Jamshidi, N., & Cohen, M.M. (2017). The clinical efficacy and safety of Tulsi in humans: A systematic review of the literature. Evidence-Based Complementary and Alternative Medicine, 2017, Article 9217567.
22. Joshi, P., Sharma, A., & Kumar, R. (2024). Comprehensive review of Adhatoda vasica: Phytochemistry, pharmacology and therapeutic applications. International Journal of Pharmaceutical Sciences and Research, 15(8), 2273-2279.
23. Jung, I.C., Lee, J.H., Lee, S.H., & Kim, B.K. (2024). Prospective proof-of-concept observational research about traditional herbal preparation treatment for chronic obstructive pulmonary disease (RESET-COPD-1). Frontiers in Pharmacology, 15, Article 1437253.
24. Kakar, M., Singh, R., & Patel, A. (2025). Evaluation of comparative efficacy of polyherbal steam inhalation therapy versus conventional treatment in respiratory tract infections. JMIR Research Protocols, 14(1), Article e58197.
25. Kokkinis, S., Lampri, E.S., & Kokkinakis, M. (2024). Plant-based therapeutics for chronic obstructive pulmonary disease: A comprehensive review of mechanisms and clinical applications. Journal of Ethnopharmacology, 318, Article 117013.
26. Kruttschnitt, E., Wegener, T., Zahner, C., & Henzen-Bücking, S. (2020). Assessment of the efficacy and safety of ivy leaf (Hedera helix) cough syrup compared with acetylcysteine in adults and children with acute bronchitis. European Journal of Pediatrics, 179(10), 1613-1620.
27. Kunnumakkara, A.B., Hegde, M., Parama, D., Girisa, S., Kumar, A., Daimary, U.D., Garodia, P., Yenisetti, S.C., Oommen, O.V., Bishayee, A., & Sethi, G. (2023). Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials. ACS Pharmacology & Translational Science, 6(4), 447-518.
28. Lee, B., Lee, H.J., & Jeong, D. (2023). Herbal medicine for the treatment of chronic cough: A systematic review and meta-analysis. Frontiers in Pharmacology, 14, Article 1230604.
29. Lopresti, A.L., Smith, S.J., Metse, A.P., & Drummond, P.D. (2022). A randomized, double-blind, placebo-controlled trial investigating the effects of an Ocimum tenuiflorum (Holy Basil) extract on stress, mood, and sleep in adults experiencing stress. Frontiers in Nutrition, 9, Article 965130.
30. Mahboubi, M. (2018). A narrative study about the role of Viola odorata as anti-tussive, anti-inflammatory, analgesic, and antipyretic agent in respiratory conditions. Journal of Integrative Medicine, 16(6), 383-389.
31. Manvar, M.N. (2023). In-vitro anti-inflammatory activity of traditionally reported poly herbal combination. Asian Journal of Pharmacy and Technology, 13(1), 1-3.
32. Panda, P., & Sahu, A. (2023). Formulation and evaluation of herbal cough syrup. Asian Journal of Pharmaceutical Research and Development, 11(2), 28-33.
33. Poursaleh, Z., Harifi, G., Mohammadzadeh, F., Ebrahimi, M., Farahbakhsh, M., Khodaie, L., & Najafi, A. (2023). Effect of herbal medicine formulation (Compound Honey Syrup) as an add-on therapy in patients with chronic obstructive pulmonary disease: A randomized clinical trial. Journal of Research in Medical Sciences, 27(1), Article 118.
34. Rahbardar, M.G., & Afshar, S. (2025). Herbal medicine approach to relieving dyspnea: A comprehensive narrative review. Current Topics in Medicinal Chemistry, 25(2), 187-201.
35. Raja, R., & Heble, M.R. (2011). Accumulation of vasicine and vasicinone in tissue cultures of Adhatoda vasica and evaluation of the alkaloids for antiviral activity. Food Chemistry, 126(3), 1060-1063.
36. Raut, N.K., Dadhe, S.S., Shinde, R.B., Navnath, C.D., & Gajare, S.B. (2024). Polyherbal antitussive syrup: Formulation, evaluation and antimicrobial assessment. Journal of Emerging Technologies and Innovative Research, 11(6), Article JETIR2406583.
37. Safari, S., Maleki-Saghooni, N., Rezaei-Sadabady, R., & Zarghami, A. (2023). Curcumin effects on chronic obstructive pulmonary disease: A systematic review and meta-analysis. Health Science Reports, 6(3), Article e1145.
38. Sakure, K., Patil, S., & Sharma, M. (2024). Development and formulation of pineapple based herbal cough syrup: Quality assessment and therapeutic evaluation. Biological Forum – An International Journal, 16(5), 104-108.
39. Satpathy, L., Sahoo, S., & Mohanty, R. (2023). Therapeutic role of Curcuma longa L. on pulmonary disorders: A comprehensive review. Letters in Applied NanoBioScience, 13(1), Article LIANBS131.005.
40. Sharifi-Rad, J., et al. (2020). Turmeric and its major compound curcumin on health: Bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications. Frontiers in Pharmacology, 11, Article 01021.
41. Sholapuri, P., Kumar, N.S., & Reddy, B.M. (2020). Beneficial effects of polyherbal formulation (Bronco-T) on formaldehyde-induced lung injury in rats: Anti-inflammatory and antihistamine properties. Pharmacognosy Magazine, 16(72), 548-555.
42. Suresh, A., Balijepalli, A.S., Dolgachev, V., Swamy, S., Madala, S.K., Hemmati, A., Raghavendran, K., & Machado-Aranda, D. (2022). The Holy Basil administration diminishes the NF-kB expression and protects alveolar epithelial cells from pneumonia infection through interferon gamma. Journal of Inflammation Research, 15, 1465-1479.
43. Truemeds Ayurveda Research Team. (2025). Adulsa benefits in Ayurveda: Respiratory health & cough management through traditional medicine. Traditional Medicine Research, 9(10), Article 63.
44. Wang, Y., Liu, X., Chen, Z., & Zhang, M. (2021). Anti-inflammatory effects of curcumin in acute lung injury: Mechanisms and therapeutic implications. Human Immunology, 82(7), 471-478.
45. WHO Traditional Medicine Programme. (2024). Global guidelines for quality, safety and efficacy of traditional herbal medicines: Updated recommendations for polyherbal formulations. World Health Organization Technical Report Series, No. 1005.
46. You, M., Li, H., Wang, S., & Chen, L. (2024). Curcumin as a promising treatment for pulmonary fibrosis: Mechanisms of action and clinical applications. Heliyon, 10(12), Article e33915.